To examine the pattern and mechanisms of enhanced intestinal nutrient absorption in diabetes, we measured intestinal transport of 3-O-methylglucose (3OMG), l-alanine (ALA), and SO4 in male Lewis rats made diabetic with streptozocin. Diabetes enhanced 3OMG absorption fivefold in ileum and threefold in jejunum; ALA absorption increased twofold in ileum but not at all in jejunum; ileal SO4 transport was unaffected. Increases in 3OMG and ALA transport were due solely to increases in maximum velocity. The enhancement of ileal glucose absorption was half-maximal in 40-45 d, could be reversed by 10 d of treatment with insulin and did not result from adrenergic denervation. The density of glucose carriers per milligram brush border protein (measured as [3H]phlorizin binding sites) was not altered but there was a sixfold increase in the number of glucose-inhibitable [3H]phlorizin-binding sites in the intact epithelium. Generalized mucosal hypertrophy accounted for less than 30% of this increase. We conclude that the intestine adapts to streptozocin-induced diabetes through recruitment of additional brush border carriers for sugar, probably in the midvillus-tocrypt region.
Introduction
Alterations in the intestinal absorption of both nutrients and inorganic ions can occur in response to dietary availability, body stores, nutrient requirements, and surgery. In human, poorly controlled insulin-dependent diabetic subjects, increased jejunal d-glucose absorption has been reported (1) . However, a separate study found no change in the absorption of a nonmetabolized glucose analogue (2) . Experimental diabetes in rats has been found to enhance diaccharidase activity but not to increase microvillus membrane protein (3) . Enhanced absorption ofamino acids, glucose, bile acids, phosphate, cholesterol, fatty acids, and fatty alcohols have also been reported (4) (5) (6) (7) (8) (9) (10) . These enhancements of absorption have been variously attributed to increased maximal transport capacity (6, 11) , increased passive permeability (1 1), alterations in unstirred water layers (1 1), and increased mucosal mass (12) (13) (14) . The mechanisms responsible for these adaptive changes remain elusive.
coupled nutrient absorptive processes that occur in the small intestine ofstreptozocin-treated rats. We first measured transport of glucose, alanine, and S04 in jejunum and ileum and then measured the change in ileal sugar transport in more detail. We determined its time course, its reversibility with insulin, and its relationships to the number of phlorizin-binding sites on the brush border and to overall mucosal hypertrophy and adrenergic denervation.
Methods

Materials
Streptozocin was obtained from UpJohn Co. (Kalamozoo, MI). Intermediate-acting beef/pork insulin (4 mg/IU) was obtained from Eli Lilly Co. (Indianapolis, IN). [3H]PEG (mol wt 900, 5 mCi/mmol), [3H]-3ortho-methyl-d-glucose (60 Ci/mmol), ['4Cj-l-alanine (150 mCi/mmol), Na35SO4 (1 13 mCi/mmol), and [3H]phlorizin (55 Ci/mmol) were obtained from New England Nuclear, Boston, MA. Hepes was obtained from Sigma Chemical Co., St. Louis, MO. The remainder ofthe chemicals (reagent grade) were also obtained from Sigma Chemical Co.
Animal preparation
Induction ofdiabetes. Male Lewis rats (250-300 g; Harlan Sprague Dawley, Inc., M. A. Laboratory Animals and Teklad Diets, Indianapolis, IN) were made diabetic with streptozocin (50 mg/kg) administered via dorsal tail vein. Diabetic and age-matched control animals were allowed access to standard rat chow and water ad lib. and housed in a light cycled animal care facility. Blood glucose concentration was determined periodically on a drop of blood obtained from the dorsal tail vein. A reflectance photometer and glucose reagent strips (Ames Division, Miles Laboratories, Inc., Elkhart, IN) were used for these determinations. Total glycosylated hemoglobin was measured by the thiobarbituric acid method (15) on blood obtained by cardiac puncture immediately after animals were sacrificed. Chronic diabetic rats (CD)' were those with persistent hyperglycemia (> 325 mg/dl) for 90-120 d.
Insulin administration. Insulin-treated rats were given intermediateacting insulin (4-6 U subcutaneously) each day at 0800 h for 10 consecutive days to maintain euglycemia. Blood glucose in each of these animals was determined daily immediately before insulin injection. Mean blood glucose was 445±26 mg/dl before insulin treatment and decreased to 151±95 mg/dl during the insulin treatment period. Mean blood glucose concentration in age-matched nondiabetic rats was 129±15 mg/dl. Sympathectomy using 6-hydroxydopamine. Using a modification of the method ofChang et al. (16) , we gave normal littermates ofthe chronic diabetic group a single dose of 6-hydroxydopamine (6-OHDA), 50 mg/ kg dissolved in 0.9% NaCl and 1% ascorbic acid, through the dorsal tail vein. 6-OHDA selectively destroys postsynaptic adrenergic neurons within the intestine (17) . 3-O-Methylglucose (30MG) transmural transport was 1. Abbreviations used in this paper: ALA, I-alanine; BBM, brush border membrane; CD, chronic diabetic rat; Isc, short-circuit current; m, mucosa; 6-OHDA, 6-hydroxydopamine; 30MG, 3-O-methylglucose; PD, potential difference; R, electrical resistance; s, serosa. measured as described below at 14 and 30 d post 6-OHDA injection. The degree of sympathectomy induced by 6-OHDA was assessed as previously described (16) . Briefly, mucosal norepinephrine stores were estimated by the short-circuit current (Isc) response to the serosal addition of 10 AM tyramine which, at that concentration, effectively releases 80% of all stored norepinephrine (18) .
Experimental preparations. Rats were sacrificed with diethyl ether overdose. 30 cm of distal ileum, ending 2 cm from the ileal cecal valve, and 30 cm of proximal jejunum, beginning just distal to the ligament ofTrietz, were quickly excised, opened along the mesenteric border, and rinsed with ice-cold normal Ringer. The serosa and outer muscle layer was then removed by dissection. Before use, all tissues were maintained in ice-cold normal Ringer solution gassed with 5% CO2 in O2. Tissues were then clamped in Ussing-type chambers and bathed on both sides by normal Ringer (in mmol/liter: Na, 144; K, 5; Ca, 1.25; Mg, 1.1; Cl, 117.5; HCO3, 25; H2PO4, 0.35; HPO4, 1.65), gassed with 5% CO2 in O2 (pH 7.4), and maintained at 370C. Transepithelial electric potential difference (PD), electrical resistance (R), and Isc were determined as previously described (19). A Cland HCO3-free Ringer solution, in which these ions were replaced by gluconate and 10 mM Tris/Hepes (pH 7.4), gassed with 100% 02, was used to determine the anion dependency of glucose-induced changes in short-circuit current. In all experiments, 40 mM fructose was added to the serosal and mucosal bathing medium to ensure sufficient substrate for energy metabolism.
Intact tissue experiments
Transmural soluteflux measurements. Transmural fluxes ofradioactively labeled 30MG, l-alanine (ALA), and SO4 were determined in duplicate in tissues taken from adjacent gut segments. Tissues were not used for paired analyses if their electrical resistances differed by > 25%. 20 min after tissues were mounted in chambers, [3H]30MG (0.25 ACi/ml), ['4C]ALA (0.15 ACi/ml), and 35SO4 (0.1 ,Ci/ml) were added to one side and unidirectional transmural fluxes from mucosa (m)-to-serosa (s) and from s-to-m (Jms and J.,,, respectively) were determined as previously described (20) during a 20-min flux period following a 25-min equilibration period. In preliminary experiments, serial flux measurements established that steady-state rates ofradioisotope transfer ofeach ofthese solutes from m-to-s and from s-to-m were present within 15 min of the addition of radioisotope (data not shown).
Morphological techniques. Jejunal and ileal mucosal sheets from control and CD animals were fixed while mounted in Ussing chambers with 1% glutaraldehyde. This initial fixation, which ensured that the tissues maintained the shape they held under chamber conditions, was followed by fixation for 2 h at 4°C in a solution of 2% paraformaldehyde, 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. After washing in cacodylate buffer, tissues were postfixed in 1% osmium tetroxide, washed again, dehydrated, and embedded in epoxy resin. To ensure that differences in structural appearance of chamber-mounted control vs. CD intestine were present before chamber mounting, transmural sections ofjejunum and ileum from these animals were also fixed, as outlined above, immediately upon removing the intestine from the animals. Oriented l-,um sections were obtained from multiple blocks of each tissue source with glass knives and oriented representative thin sections were obtained with diamond knives.
To compare mucosal surface lengths per unit intestinal length between control and CD animals, 12 l-gm sections of ileal mucosa, each containing at least six oriented villi, were photographed and photomicrographs were printed at final magnifications of 450 X. Morphometric analysis of these micrographs was performed using a Zeiss Videoplan Morphometry Unit. The surface length of the mucosa from each block was traced with the magnetic stylus, expressed as units of surface length per unit muscularis mucosa length, and data obtained from each block was treated as an individual measurement.
Because no discernable differences were detected by electron microscopy between either the length or density of microvilli in control as compared with CD-absorptive cells, we arbitrarily selected oriented absorptive cells in the midvillus zone to quantitate microvillus height, width, and density, i.e., parameters that relate to surface area expansion of the absorptive cell apical membrane by microvillus projections. Because microvillus heights are extremely uniform in individual absorptive cells, microvillus height for each cell was determined by direct measurement of one microvillus from an electron photomicrograph printed at 15,000 X. Only microvilli cut in a central plane parallel to their axis were selected for measurement. Totals of 47 and 62 measutements were taken from control and diabetic rats, respectively. Widths of these microvilli were also obtained with the use of a calibrated ocular micrometer and microvillus densities were assessed by counting the number of microvilli per 4 ,um of absorptive cell width in each block at the midvillus site.
Phlorizin binding to intact tissue. Binding of [3H]phlorizin to intact tissue was measured at 370C in modified influx chambers (21, 22) following a 20-min equilibration period. The luminal surface was bathed in normal Ringer solution containing either 40 mM d-glucose or 40 mM fructose for 2 min before addition of [3H]phlorizin (0.89 1AM, 50 gCi/ ml). The serosal surface was bathed in normal Ringer solution containing 40 mM fructose. 2 min following addition of phlorizin, the phlorizincontaining solution was removed and the tissue surface washed with 5 ml of ice-cold 300 mM mannitol. The tissue was then punched out, blotted on absorbant paper, and placed in 1 ml of 10% perchloric acid. After 24 h the samples were vortexed and the supernatant was dissolved in 4 ml scintillation fluid and assayed for radioactivity. Specific binding was determined from the difference between binding in the presence of fructose, i.e., total binding, and binding in the presence of glucose, i.e., nonspecific binding. Nonspecific binding never exceeded 20% of total binding.
Membrane vesicle experiments
Brush border membrane preparation. 30 cm of ileum beginning just proximal to the ileo-cecal valve was quickly excised, rinsed with ice-cold normal Ringer solution, and opened along its mesenteric border. The mucosa was then scraped from underlying muscle with a glass slide and used for membrane isolation. Two rats were usually required for one vesicle preparation. Light microscopy revealed that mucosal scraping removed the upper half of the villus, leaving the remainder of the lower villus-crypt structure attached to underlying muscle and connective tissue (data not shown). These results of mucosal scraping are similar to others (14) . Brush border membrane (BBM) vesicles were freshly prepared on the day of experiment according to the procedure of Kessler et al. (23) . Purification ofBBMs was assessed by measurement ofsucrase and alkaline phosphatase activities, expressed as Amol/mg protein/h (24). Alkaline phosphatase was, on the average, enriched 14-fold in the BBM fraction, (64.8±4.8 and 80.2±3.6) compared with whole homogenate (4.2±0.4 and 4.9±0.3) in control and CD, respectively. Sucrase was, on the average, enriched 17-fold in the BBM fraction, (37.8±3.0 and 47.4±3.6) compared with whole homogenate (2.3±0.2 and 2.8±0.3) in control and CD, respectively. Enrichments were the same for CD and control rats but enzyme-specific activities were slightly higher in CD rats. Protein was estimated according to Lowry et al. (25) using bovine serum albumin asstandard.
Phlorizin binding to brush border membrane vesicles. Binding of
[3H]phlorizin to BBM was carried out at room temperature as described by Toggenburger et al. (26) . Briefly, 10 Ml of vesicles were placed at the bottom of a microfuge tube. 10 Ml of incubation medium containing radiolabeled phlorizin was positioned on the side of the tube. At time zero the two drops were rapidly mixed by tapping the bottom of the microfuge tube. The composition of the combined media was in mol/ liter: mannitol, 0.1; NaSCN 0.1; Tris-base, 0.02, buffered to pH 7.2 with 1 N HCl; d-glucose or fructose, 0.025; and [3H]phlorizin, 2 X l0-' to l0-4 (12 ,uCi/ml). Binding was carried out in the presence ofan inwardly directed 100 mM NaSCN gradient since Tannenbaum et al. (27) have shown that a transmembrane potential (inside negative) is required for binding of phlorizin to the glucose cotransporter. Because binding of phlorizin to the Na-dependent glucose carrier is virtually complete in 2 s (26) , and because nonspecific binding becomes excessive after this time period (26) , phlorizin binding studies were stopped at 2 s with I ml icecold 150 mM NaCl. The sample was then rapidly filtered through a 0.45-Mm nitrocellulose filter (Schleicher & Schuell, Inc., Keene NH) and Statistical analysis. Results are presented as means±SEM. Two-tailed Student's t test of unpaired data was used to analyze differences between diabetes and age-matched controls.
Results
Animal groups. Streptozocin-treated rats were compared with age-matched untreated littermates. Following streptozocin injection blood glucose determinations were > 325 mg/dl within 24 h. Unlike nondiabetic control rats, diabetic rats failed to gain weight after induction of diabetes ( Fig. 1 ). Blood glucose glycosylated hemoglobin and body weight of CD animals, 120 d following streptozocin injection, and age-matched control animals are shown in Table I . It can be seen that CD animals weighed less and had higher blood glucose and glycosylated hemoglobin concentrations than did control animals. Periodic measurements of serum electrolytes and blood urea nitrogen showed no differences between the two groups of animals.
Na-dependent solute transport across jejunum and ileum in vitro. Unidirectional and net fluxes of 30MG, ALA, and SO4, measured at medium concentrations of 20, 5, and 0.2 mM, respectively, are shown in Table II . All three solutes are absorbed by Na-dependent cotransport systems. In control rats, net transmural fluxes of 30MG across jejunum and ileum were similar in magnitude. In CD rats, the net flux of 30MG was increased 3. 1 -fold injejunum and 5.1 -fold in ileum. Phlorizin, a nontransported ligand of the Na-glucose cotrahsporter (27), completely blocked net transmural 30MG flux in both control and CD ileum. The phlorizin effect was exerted only on the m-to-s unidirectional fluxes; the s-to-m fluxes remained unchanged. Furthermore, the phlorizin concentration required to inhibit 50% of the increase in Isc induced by 20 mM 30MG was similar in ileum from control (2.3±0.4 uM) and CD (3.0±0.6 ,uM) rats (Fig. 2 ). Thus the stimulation ofglucose absorption that develops in the diabetic state is not due to induction of a phiorizin-independent carrier or of one less sensitive to phlorizin.
The net transmural flux of ALA was larger in the ileum of control rats than in the jejunum. In the CD rat, the net flux of ALA was increased 2.2-fold in ileum, but was unchanged in jejunum. The observed increases in net flux were due mainly, if not exclusively, to increases in rn-to-s unidirectional fluxes. In both control and CD rats, SO4 absorption was detected only in ileum, consistent with previous observations (28) . Ileal S04 transport was the same in CD and control rats. Therefore, there did not appear to be a uniform alteration ofNa-coupled transport pathways in CD rats.
Isc changes produced by 30MG also proved to be independent ofthe anions in solution. Thus glucose-induced Isc changes in diabetics and controls were the same in magnitude when the Ringer solution contained Cl and HCO3 as when these anions were replaced with gluconate and Hepes, respectively (data not shown). Kinetic analysis. To assess whether the enhanced absorptions of 30MG and ALA observed in the CD rats were due to changes in maximal transport capacity (Vma.), changes in carrier affinity (K:0.5), or both, we determined Isc responses to varying concentrations of the two nutrients (concentration ranges 30MG, 5-120 mM, ALA 0.5-64 mM). Measurements were made in jejunum and ileum of both CD and control rats. Results, plotted as rate of 30MGor ALA-stimulated Na transport (AIsc/cm2) vs. concentration of 30MG or ALA, can be fit by a rectangular hyperbola for each solute. Eadie-Hofstee plots of the data for 30MG are shown in Fig. 3 A and for ALA in Fig. 3 B. As shown in Table III , CD increased the Vmax, for the 30MG-induced change in Isc 8.3-fold in ileum and 2.4-fold injejunum. In control rats and in contrast to the results for 30MG, the Vm. for the ALA-stimulated change in Isc was larger in the ileum than in the jejunum. CD increased this V,. 1.6-fold in the ileum but had no effect in the jejunum. The relative changes in Vm., for 30MG and ALA-stimulated changes in Isc, are similar to the relative changes in transmural fluxes of30MG and ALA shown in Table II. CD did not significantly affect affinity for transport ofeither 30MG or ALA ( Fig. 3 and Table III ). K0.5 values for 30MG in jejunum and ileum of CD and control rats did not differ significantly. Enhanced absorption of 30MG and ALA in CD rats is not due to changes in carrier affinity, therefore, but to an increase in the number ofcarriers or their rate ofturnover or to an increase in the electrochemical gradient for net uptake across the brush border.
Time course of enhanced glucose transport in chronic diabetes. To examine the development of enhanced glucose transport over time and to assess the role mucosal hypertrophy may play, ileal 30MG fluxes ( Fig. 4 A) and ileal dry weight/cm2 (Fig. Effect ofinsulin treatment on glucose transport. To determine if in vivo insulin administration could reverse the observed enhancement of intestinal glucose transport in CD rats, insulin was given to some ofthe CD rats daily for 10 d. Results for these rats were compared with untreated CD rats and age-matched controls. As shown in Table IV , 30MG-stimulated Isc responses were significantly higher in non-iisulin-treated CD animals than in age-matched controls. Correction of hyperglycemia for 10 d with insulin completely reversed the change in Isc response to glucose observed in CD rats. This difference could only be produced in vivo. When added to ileal mucosa in vitro, 100 AM insulin did not alter Isc responses to glucose in either control or diabetic rat ileum when these were tested 60 min after insulin addition (data not shown). Effect ofchemical sympathectomy with 6-hydroxydopamine. Altered fluid and electrolyte transport in ileum and colon ofCD rats has been shown to be due to impaired alpha-2 adrenergic innervation of enterocytes (18, 29) . Rats treated with 6-OHDA develop both alpha-2 adrenergic denervation and impaired intestinal fluid absorption similar to the changes observed in CD (16) . Accordingly, we investigated whether sympathetic denervation with 6-OHDA would alter intestinal glucose absorption in nondiabetic rats.
Similar degrees of sympathetic denervation, as assessed by responses to tyramine (see Methods), were achieved in 6-OHDAtreated control rats and in non-6-OHDA-treated CD rats (responses to tyramine were 13±3 and 12±6 MA/cm2, respectively). These represent 50% of control (27±3 MA/cm2) tyramine responses. However, net transmural flux of 20 mM 30MG in animals treated with 6-OHDA for 14 or 30 d was not enhanced. Mean glucose absorption was in fact slightly, though not significantly, lower in 6-OHDA-treated rats than in controls (J.,, in control rats was 0.64±0.20; Jnet in 6-OHDA-treated rats was 0.45±.09 at 14 d and 0.46±.03 at 30 d following injection). In addition, administration of 6-OHDA to rats previously made diabetic with streptozocin enhanced the degree of sympathectomy (response to tyramine: 2±1 MA/cm2) but did not alter 30MG transport when compared with those treated with streptozocin alone (data not shown). We conclude that adrenergic denervation does not enhance intestinal glucose absorption.
Morphometric analysis. Jejunal and ileal mucosa, removed from CD and control animals and directly placed into fixative, had normal structural appearances. Mucosal preparations first mounted in chambers and equilibrated there for 30-40 min prior to fixation, maintained epithelial integrity but showed the elements of the lamina propria to be separated from one another more than they were in the freshly fixed tissues, giving the lanIina propria a lucent appearance and slightly widening the villi (Fig.  5 ). In our experience these features are commonly found in absorbing chamber-mounted intestinal epithelia and are likely due to the absence of an intact vasculature with a resulting accumulation of subepithelial fluid. Morphometric analysis of chamber-mounted ileal mucosa revealed a 1.5-fold greater villus height in CD animals than in controls. The mucosal surface length was 3.5±0.2 times the muscularis mucosal length in diabetic animals but only 2.3±0.2 times the muscularis mucosal length in controls, P < 0.02 (Fig. 5 ).
Electron microscopic analysis of the microvilli in a midvillus ileal enterocyte revealed that the microvilli expand intestinal surface area to a similar degree in CD and control rats (Fig. 6 ). Morphometric analysis revealed that microvillus height was similar in both animal groups (1.05±0.03 ,uM and 1.06±0.03 ,MM, control and CD, respectively). Similarly, microvillus densities (7.11±0.34 microvilli per MM absorptive cell width in controls and 7.06±0.46 in CD rats) and microvillus widths (0.1 1±0.1 and 0.10±0.02 gM in control and CD rats, respectively) were the same for the two animal groups.
[3H]Phlorizin binding to isolated brush border membranes.
The possibility that diabetes increases intestinal glucose absorption by increasing the number of carriers in the brush border membrane was explored by first quantitating the number ofNadependent glucose carriers per milligram brush border protein using [3H]phlorizin. Fig. 7 compares specific phlorizin binding to ileal BBM prepared from CD rats and age-matched controls. Fig. 6 .
The statistical analysis is described in Methods. * Different than corresponding value in controls, P < 0.02.
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A ---2-----2' [3H]Phlorizin binding to intact epithelium. Because the phlorizin-binding properties of BBM derived from the villus tip region were similar for CD and control animals, we measured
[3H]phlorizin binding to intact mucosa to determine the total number of phlorizin-inhibitable glucose carriers present in the brush border membrane ofthe epithelium. Many ofthese carriers could be present in the midvillus region below the region used to prepare BBM (see Methods). Sampling of the serosal bathing t 5 ; l~t
,~1
I.~~~~~P Figure 5 . Light micrographs of chamber-mounted ileal mucosal sheets from control (top) and chronically diabetic (bottom) animals. The intestinal surface area of diabetic animals was expanded to a greater degree by villi (brackets) than control animals. Quantitative measurements revealed chronically diabetic animals had 1.5-fold greater amplification of ileal mucosal surface area than did control animals as a result of this morphological difference. The epithelium is well maintained in these stripped preparations (both -X 12). rats. Binding was 6.6-fold greater in CD than in control rat ileum (Table V) . The relative effects of CD on phlorizin binding to intact ileum and on 30MG transport were determined on paired tissues from the same animals and proved to be similar (Table  V) . These results suggest a "recruitment" of Na-dependent glucose carriers into the lower villus region of the ileal epithelium.
Discussion
These results describe the pattern of adaptation of Na-coupled nutrient absorption in rats made diabetic with streptozocin. Because the diabetic state involves an inability to utilize circulating glucose at the cellular level and a loss of glucose in the urine, increased absorption of oral nutrients may represent a compensatory response. The simplest nonspecific means for such a response would be an increase in mucosal mass to uniformly increase absorption of all nutrients. In prior studies, however, intestinal glucose transport in rats was found to begin increasing within 4 h ofinduction ofthe diabetic state and to be significantly higher than control by 48 h, well before changes in mucosal morphology could be detected (32) .
A simple increase in intestinal mass is unlikely, therefore, to explain enhanced glucose transport in experimentally induced diabetics. A more specific change ofintestinal absorption appears likely. The results of the present study are consistent with this conclusion. During the first 10 d after streptozocin administration diabetic rats lost 20% of their body weight. Following development ofhyperphagia, weight was rapidly regained to preinjection levels and then remained constant for at least the next 100 d. Normophagic age-matched controls injected with saline did not demonstrate the initial loss ofbody weight, and over the similar 120-d period doubled their body weight (Fig. 1 ). It is unlikely, however, that differences in body weight, growth, or food consumption are directly responsible for the observed enhancements ofnutrient absorption. Increases in intestinal glucose absorption have been reported for normophagic diabetic rats fed a low-carbohydrate diet (33) and for diabetic rats pair-fed with nondiabetic controls (8) . In addition, Crane (34) has shown an increase in intestinal glucose absorption in diabetes whether ageor weight-matched controls are used.
The present study confirms these prior observations in two respects: (a) Although enhanced glucose absorption was slow to develop, reaching a maximum between 45 and 60 d after injecting streptozocin, relative intestinal hypertrophy, as evidenced by an increase in dry weight per square centimeter and an am-plification of villus height, was even slower to develop and was not significantly different from control at 90 d. Furthermore, the maximum increases in ileal dry weight and villus height were only 1.5-fold, which cannot account for the greater than five-fold increase in glucose transport. (b) The enhancement of active ileal absorption ofsolutes was also not uniform, the change being 5. 1-fold for glucose and 2.2-fold for ALA. S04 transport, in contrast, was unaltered.
It is worth noting that 10 d of insulin therapy completely reversed the increase in glucose absorption that occurs in experimental diabetes. Thus the off-rate for this stimulation was faster than the on-rate. The reasons for this discrepancy are not at present clear.
The nature ofthe epithelial alteration(s) leading to increased nutrient absorption were explored mainly with sugar transport probes. For both 30MG and ALA, the observed adaptation involves increases in m-to-s unidirectional fluxes but no significant changes developing in the s-to-m fluxes. Furthermore, the observed changes for both nutrients, reflected increases in Vmax without any changes in carrier affinity, so there were either more carriers present per square centimeter surface area, a more rapid translocation through preexisting carriers, or less recycling though the carriers from cell to lumen, implying a greater electrochemical gradient for glucose and, to a lesser extent, alanine. The last of these possibilities seems very unlikely because the electrochemical gradient for Na and sugar or alanine is normally sufficiently steep to obviate a subtantial back flux through the carrier (35) . Furthermore, ileal S04 transport, which also depends on the Na gradient (36) , was unaltered in CD. Similarly, alanine transport in the jejunum was unaffected by CD, whereas 30MG transport was affected, and it was altered far less than was 30MG transport in the ileum. Thus the effect of CD on sugar transport appears to be sufficiently unique to rule out a general effect on the Na gradient.
The second of these possibilities is also unlikely because Brasitus and Dadeja (37) , using the identical rat model, demonstrated that the intestinal microvillus membranes of CD rats have a lower lipid fluidity than do those of control rats. In consequence, an increase in carrier mobility in the diabetes-modified membrane seems improbable because lower lipid fluidity is generally associated with decreased, not increased, transport (38) .
A change in [3H]phlorizin binding to the mucosal surface of the intact epithelium parallels exactly the observed increase in 30MG transport (see Table V ) and suggests an overall increase in the number of sugar carriers as the explanation for the enhancement of sugar absorption. It is of interest that this overall increase was not reflected in an increase in the density of carriers near the villus tip, because there was no difference in isolated brush border membrane vesicles in specific [3H]phlorizin binding. In preparation of membrane vesicles for the latter study, the villus tip region of the epithelium was employed due to light scraping of the mucosa before homogenization. This was confirmed by light microscopy of the tissue remaining after scraping. Thus, in the intact epithelium, a much larger fraction of mucosal surface area must have been recruited for sugar absorption. Radioautographic studies to test this hypothesis support this conclusion (Fedorak et al., manuscript in preparation).
The cellular signals responsible for these adaptive changes are presently unclear. Adrenergic denervation does not seem to play a role. We are currently exploring the roles of both insulin and glucagon in intestinal adaptation. Glucagon in particular Intestinal Adaptation to Diabetes 1577 has been noted to increase protein synthesis and DNA synthesis in rat ileum (39) .
